Ausgehend von allgemeinen Informationen zum Land über Hintergrundinformationen zum Konflikt (Wirtschaftskrise und politische Krise) werden auch die Menschenrechtsverletzungen durch die Regierung beschrieben. Der Bericht geht in diesem Zusammenhang auf die Aktivitäten der zahlreichen bewaffneten Gr...uppen (Armee, Sicherheitsdienste und "Colectivos") sowie die Rolle des staatlichen Öl- und Gaskonzerns Konzerns "PDVSA" ein. Schließlich behandelt er die Situation der Bevölkerung unter dem Blickwinkel des Zugangs zu sozialen Sicherungssystemen.
more
WHO REPORT ON THE GLOBAL TOBACCO EPIDEMIC, 2017
The new treaty aims at eliminating all forms of illicit trade in tobacco products. It provides tools for preventing illicit trade by securing the supply chain, including by establishing an international tracking and tracing system, by countering illicit trade through dissuasive law enforcement measu...res and a suite of measures to enable international cooperation.
more
An example of integration of research into epidemic response.
STP Guidelines, First Edition 2017
Research Paper.
As the fighting in Syria winds down, international humanitarian organisations (IHOs) operating from Damascus are hopeful that the Syrian government’s interference in their work will decrease. However, the government is attempting to formalise its influence over humanitarian operat...ions.
Throughout the Syrian conflict, the government has imposed multiple administrative processes on humanitarian organisations to limit their ability to operate independently. This includes restricting the operational environment; undermining organisational independence; imposing local partners; influencing procurement procedures; and preventing direct monitoring and evaluation.
While some level of coordination with the government might be a pragmatic necessity to ensure the safety of operations in regime-controlled areas, this cooperation should not enable the government to use aid for military or political purposes. Consequently, international humanitarian organisations have an ethical dilemma in how they provide aid in these areas without undermining their principles of humanity, independence, impartiality and neutrality.
more
UNAIDS/99.31E (English original, June 1999)
1st revision, April 2000
HIV Diagnostics
Information Note
WHO/HIV/2017.16
Public Report
PQMC 0001-001-04 WHO PQMC Public Report November/2016, version 8.0
Barbados currently has a rudimentary framework and capacity to address the issue of antimicrobial resistance. There however needs to be coordination of efforts and improvement in areas where gaps have been identified.Actions required include improved antibiotic stewardship in healthcare settings, pr...evention of the spread of drug-resistant organisms//bacteria, elimination of the use of medically-important antibiotics for growth promotion in food animals, and expanded surveillance for drug-resistant bacteria in humans and animals.
The National Action Plan will provide the roadmap to guide Barbados in the effort to address the urgent and serious threat of AMR and will be organized around three goals for collaborative action.
more
File No.C.13015/03/2020-PG
No. C.13015/03/2020- PG
Nirman Bhawan, New Delhi Dated the 31st March, 2020
The document "Priority medical devices list for the COVID-19 response and associated technical specifications" complements this guideline.
This document provides interim guidance on the quality, performance characteristics and related standards of personal protective equipment (PPE) to be used i...n the context of COVID-19. This includes WHO Priority Medical Devices, specifically: surgical masks, non-surgical masks, gloves, googles, face shields, gowns and N95 masks. It is intended for procurement agencies, occupational health departments, infection prevention and control departments or focal points, health facility administrators, biomedical and materials engineering, PPE manufacturers and public health authorities at both national and facility levels.
more
This document is part three in a series of explainers on vaccine development and distribution. Part one focused on how vaccines work to protect our bodies from disease-carrying germs. Part two focused on the ingredients in a vaccine and the three clinical trial phases.
This document outlines the... next part of the vaccine journey: the steps from completing the clinical trial phases through to distribution.
more
AstraZeneca-SKBio in South Korea and Serum Institute of India